Local News

Two More Measles Cases Confirmed in San Diego



Date: March 6, 2014

Two more San Diego residents were confirmed today to have measles after exposure to an ill individual who returned from a recent trip to the Philippines. The County of San Diego Health and Human Services Agency (HHSA) issued a press release today notifying the public about potential exposures at the following locations:

  • Pettit Kohn law offices, 11622 El Camino Real, Suite 300, San Diego, on Feb. 28 from 8am to 7pm and March 3 from 8am to 10am;
  • Naval Base San Diego Commissary, 2525 Callagan Highway, Bldg. 3629, San Diego, on March 1 between 1pm and 4pm;
  • Sharp Rees-Stealy (SRS) Sorrento Mesa Urgent Care Center, 10243 Genetic Center Drive, San Diego, on March 3 from 4pm to 8pm;
  • Sharp Rees-Stealy (SRS) Sorrento Mesa Primary Care, 10243 Genetic Center Drive, San Diego, on March 4 from 12:30pm to 6pm.

HHSA public health officials will be contacting individuals who were registered patients at the listed medical locations during the exposure periods to determine if they are at risk for developing measles.

People who have not been vaccinated, or who have not had measles, may contact their providers for evaluation and preventive treatment if appropriate. Click here for guidance from the California Department of Public Health (CDPH) on measles post-exposure prophylaxis (PEP).

The number of reported measles cases in California in 2014 is now 23 with four other possible cases under investigation. Medical providers should review their infection control procedures and proactively document measles immunity for all staff members at medical facilities. Click here for CDPH guidance on healthcare facility infection control recommendations for suspect measles patients.

If measles is suspected in a patient, immediately notify the County Epidemiology and Immunization Services Branch (EISB) (866) 358-2966 Monday–Friday 8am–5pm and (619) 692-8499 after hours and on weekends. Questions about PEP management may also be directed to EISB.



Comments are closed.